首页> 外文期刊>Molecules >Oral Intake of Carboxymethyl-Glucan (CM-G) from Yeast (Saccharomyces uvarum) Reduces Malondialdehyde Levels in Healthy Men
【24h】

Oral Intake of Carboxymethyl-Glucan (CM-G) from Yeast (Saccharomyces uvarum) Reduces Malondialdehyde Levels in Healthy Men

机译:从酵母(酵母菌)中摄取羧甲基葡聚糖(CM-G)可降低健康男性的丙二醛水平

获取原文
获取原文并翻译 | 示例
           

摘要

Carboxymethyl-glucan (CM-G) is a water-soluble derivative of (13)(16) glucan, a well-known immunostimulant and antioxidant compound. In this experimental, randomized and placebo-controlled study, the effects of oral CM-G intake over a 60-day period on the peripheral blood, cholesterol, glycemic index and malondialdehyde (MDA) levels of healthy men was assessed. The CM-G was obtained from spent brewer's yeast (S. uvarum) with DS 0.8 and molecular weight of 2.2 x 10(5) Da. Following CM-G administration, no changes were observed in red and white blood cell, hematocrit, hemoglobin and platelet counts, or in cholesterol and glycemic indices. After 30 days of CM-G administration, the MDA levels decreased significantly (p 0.05) in men receiving CM-G. The results showed for the first time that CM-G may act as an adjuvant in preventing oxidative damage in healthy humans.
机译:羧甲基葡聚糖(CM-G)是众所周知的免疫刺激和抗氧化剂化合物(13)(16)葡聚糖的水溶性衍生物。在这项实验性,随机性和安慰剂对照研究中,评估了60天内口服CM-G摄入对健康男性外周血,胆固醇,血糖指数和丙二醛(MDA)水平的影响。 CM-G从啤酒废酵母(S. uvarum)中获得,DS为0.8,分子量为2.2 x 10(5)Da。 CM-G给药后,未观察到红细胞和白细胞,血细胞比容,血红蛋白和血小板计数或胆固醇和血糖指数的变化。服用CM-G 30天后,接受CM-G的男性的MDA水平显着降低(p 0.05)。结果首次表明,CM-G可以作为预防健康人氧化损伤的佐剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号